Ashley Coker Prince
Friday, December 10, 2021
Dedicated partnerships prove essential in evolving pharma field
While decentralized trails seem like a win-win-win, one of the biggest concerns surrounding this model is the safety and integrity of the drug when it is shipped to the patient’s home. This direct-to-patient model relies on a robust logistics strategy to support product viability and security.
